II. Definitions
- Neurotransmitter
- Endogenous signaling molecules affecting Neuron behavior by acting at nerve Synapse, Muscle Cells and glands
- Neurotransmitters are synthesized and released by Neurons
III. Physiology: Neurotransmitters in General
- More than 500 Neurotransmitters have been identified in humans
- Chemical Structures
- Amino Acids (e.g. Glutamate, Aspartate, Gamma-Aminobutyric Acid or GABA, Glycine)
- Monoamines (e.g. Dopamine, Norepinephrine, Epinephrine, Histamine, Serotonin)
- Peptides (Oxytocin, Somatostatin, substance P)
- Purines (Adenosine Triphosphate or ATP, Adenosine)
- Miscellaneous (Acetylcholine or ACh)
- Function
- Excitatory Neurotransmitters
- Acetylcholine
- Norepinephrine
- Glutamate
- Excitatory Amino Acid (EAA) facilitate CNS Neuron depolarization
- Increases cation conductance and phostatidyl Inositol turnover
- Important Neurotransmitter in memory and learning
- Implicated in pathogenesis of Alzheimer's Disease, huntington disease, Seizure Disorder and ALS
- Excitatory Amino Acid (EAA) facilitate CNS Neuron depolarization
- Inhibitory Neurotransmitters
- Dopamine
- Produced in Substantia Nigra and released into Basal Ganglia
- Gamma-Aminobutyric Acid (GABA)
- Broad distribution (see below)
- Glycine
- Produced in spinal cord
- Serotonin
- Produced in median raphe and Hypothalamus
- Dopamine
- Neurotransmitters with Sedative and Analgesic properties (Opioid-like)
- Endorphins
- Enkephalins
- Excitatory Neurotransmitters
- Neuroendocrine Brain Regions (Pigmented Regions)
- Locus Ceruleus
- NorepinephrineSecreting nucleus in pons
- Important in wakefulness and attention
- Substantia Nigra
- DopamineSecreting region in Midbrain
- Substantia Nigra degeneration results in Dopamine deficiency and Parkinsonism
- Locus Ceruleus
IV. Physiology: GABA and NMDA
- N-methyl-D-Aspartate (NMDA) receptor
-
Gamma-Aminobutyric Acid (GABA) receptor
- GABA Agonists bind GABA Receptors, resulting in inhibition
- GABA Receptors are down regulated in chronic Alcohol Abuse
V. Physiology: Neurotransmitter at Synapse
- Medications affecting Precursor Uptake
- L-Phenylalanine
- L-Tyrosine
- L-Dopa
- Dopamine (DA)
- Norepinephrine (NE)
- Epinephrine (E)
- L-Tryptophan
- 5-Hydroxytryptophan,
- 5-Hydroxytryptamine (5-HT) = Serotonin
- Choline/lecithin + AcetylCoA => Acetylcholine (Ach)
- Medications affecting Synthetic Enzymes
- Metyrosine (Demser) blocks Tyrosine hydroxylase
- Decrease DA, NE, E, 5HT
- Methyldopa (Aldomet) blocks decarboxylation
- Decrease DA, NE, E, 5HT
- Metyrosine (Demser) blocks Tyrosine hydroxylase
- Medications affecting Transfer into Vesicle
- No clinically available drugs
- Medications affecting Vesicle storage
- Medications affecting Vesicle mobilization
- Affects Nerve Impulse Conduction Vesicle release
- Electroconvulsive Therapy decreases DA, NE, E, 5HT
- Medications affecting Post-synaptic receptors
- Reversible receptor blockade by Neuroleptics (Haldol)
- Medications affecting Neurotransmitter reuptake
- Reuptake inhibition by all Antidepressants (Prozac)
- Medications affecting Neurotransmitter breakdown
- No drugs available
- Medications affecting Neurotransmitter dilution
- No drugs available
- Medications affecting Neurotransmitter breakdown
- Monamine oxidase inhibitor (MOAi) (Parnate, Nardil)
- Tacrine Inhibits Acetylcholinesterase
- Increases Acetylcholine
VI. Physiology: Neurotransmitter Theory applied to Psychiatric Medication
-
Neuroleptics
- Deplete Neurotransmitter Stores
- Rauwolfia alkaloids (e.g. Reserpine)
- Phenothiazine: Chlorpromazine (Thorazine)
- Thioxanthenes: Thiothixene (Navane)
- Butyrophenones: Haloperidol (Haldol)
- Receptor blockade
- Lithium Carbonate
- Interferes with Neurotransmitter storage Na-K Pump
- Deplete Neurotransmitter Stores
- Stimulants
- Mimic Neurotransmitter at storage or Receptor sites
- Amphetamines: Methamphetamine (Methedrine)
- Benzyl-piperidines: Methylphenidate (Ritalin)
- Mimic Neurotransmitter at storage or Receptor sites
-
Antidepressants: MAO Inhibitors
- Monoamine Oxidase (MAO) is a naturally in-vivo enzyme that metabolizes Serotonin and Norepinephrine
- Inactivation or inhibition of MAO results in increased levels of Serotonin and Norepinephrine
- Tranylcypromine (Parnate)
- Inactivate MAO
- Polycyclic: Imipramine HCl (Tofranil)
- Inhibit MAO reuptake
- Monoamine Oxidase (MAO) is a naturally in-vivo enzyme that metabolizes Serotonin and Norepinephrine
-
Antidepressants: SSRI and SNRI
- Decreased Serotonin and norephinephrine are associated with Major Depression
- Reuptake inhibitors increase these Neurotransmitters in the Synapse by blocking reuptake
VII. Resources
- Neurotransmitters (Wikipedia)
VIII. References
- Goldberg (2014) Clinical Physiology, MedMaster, p. 88
Images: Related links to external sites (from Bing)
Related Studies
Definition (CHV) | a chemical substance produced by nerve cells or hormone that delivers neurologic signals |
Definition (CHV) | a chemical substance produced by nerve cells or hormone that delivers neurologic signals |
Definition (NCI) | Endogenous signaling molecules that alter the behavior of neurons or effector cells. Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. Included are neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not acting at synapses. |
Definition (NCI_NCI-GLOSS) | A chemical that is made by nerve cells and used to communicate with other cells, including other nerve cells and muscle cells. |
Definition (MSH) | Endogenous signaling molecules secreted by neurons that alter the behavior of neurons or effector cells. Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. Included are neuromodulators, neuroregulators, neuromediators, neurohormones, and neurohumors, whether or not acting at synapses. |
Definition (PSY) | Chemical substances, synthesized and released by nerve cells, or glandular hormones that excite or inhibit other nerve, muscle, or gland cells by producing a brief alteration in the postsynaptic membrane of the receiving cell. Use a more specific term if possible. |
Definition (CSP) | any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron and travel across the synaptic cleft to either excite or inhibit the target cell; included are neuromodulators, neuroregulators, neuromediators, neurohormones, and neurohumors, whether or not acting at synapses. |
Concepts | Neuroreactive Substance or Biogenic Amine (T124) |
MSH | D018377 |
SnomedCT | 35069000 |
English | SUBSTANCES NERVE TRANSM, TRANSM SUBSTANCES NERVE, NEUROTRANSM, NERVE TRANSM SUBSTANCES, neurotransmitter, neurotransmitters, Neurotransmitter (substance), Neurotransmitter, NOS, Nerve Transmitter Substances, Neurotransmitters, Substances, Nerve Transmitter, Transmitter Substances, Nerve, Neurotransmitter |
Czech | neurotransmitery |
French | Neuromédiateurs endogènes, Médiateurs chimiques, Neurotransmetteurs, Neurotransmetteur |
German | Neurotransmitter, Transmittersubstanzen, Neuro- |
Italian | Neurotrasmettitori, Neurotrasmettitore, Sostanze neuro trasmettitrici |
Spanish | neurotransmisores (sustancia), neurotransmisores |